Thalidomide for the treatment of gastrointestinal bleeding due to angiodysplasia in a patient with glanzmann’s thrombasthenia

Hematology Reports

Volumn 9, Issue 2, 2017, Pages 53-55

  Duarte, Bruno K L ^a   De Souza, Sílvia M ^a   Costa Lima, Carolina ^a   Medina, Samuel S ^a   Ozelo, Margareth Castro ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Angiodysplasia; Gastrointestinal bleeding; Glanzmann's thrombasthenia; Thalidomide

Indexed keywords

HEMOGLOBIN; THALIDOMIDE;

ADULT; ANGIODYSPLASIA; ARTICLE; CASE REPORT; DRUG EFFICACY; FAMILY HISTORY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLANZMANN DISEASE; HUMAN; MENORRHAGIA; MIDDLE AGED;

EID: 85020872614     PISSN: 20388322     EISSN: 20388330     Source Type: Journal    
DOI: 10.4081/hr.2017.6961     Document Type: Article

References (20)

1. Rydz N, James PD. The evolution and value of bleeding assessment tools. J Thromb Haemost 2012;10:2223-9.
2. Foutch PG. Angiodysplasia of the gastrointestinal tract. Am J Gastroenterol 1993;88:807-18.
3. Makris M, Federici AB, Mannucci PM, et al. The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease. Haemophilia 2015;21:338-42.
4. Sami SS, Al-Araji SA, Ragunath K. Review article: gastrointestinal angiodysplasia-pathogenesis, diagnosis and management. Aliment Pharmacol Ther 2014;39:15-34.
5. Ge ZZ, Chen HM, Gao YJ, et al. Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation. Gastroenterology 2011;141:e1-4.
6. Invernizzi R, Quaglia F, Klersy C, et al. Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study. Lancet Haematol 2015;2:e465-73.
7. Engelen ET, van Galen KP, Schutgens RE. Thalidomide for treatment of gastrointestinal bleedings due to angiodysplasia: a case report in acquired von Willebrand syndrome and review of the literature. Haemophilia 2015;21:419-29.
8. Di Minno G, Coppola A, Di Minno MN, Poon MC. Glanzmann’s thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues. Thromb Haemost 2009;102:1157-64.
9. Sanchez-Capilla AD, De La Torre-Rubio P, Redondo-Cerezo E. New insights to occult gastrointestinal bleeding: From pathophysiology to therapeutics. World J Gastrointest Pathophysiol 2014;5:271-83.
10. Randi AM, Laffan MA, Starke RD. Von Willebrand factor, angiodysplasia and angiogenesis. Mediterr J Hematol Infect Dis 2013;5:e2013060.
11. Franchini M, Mannucci PM. Von Willebrand disease-associated angiodysplasia: a few answers, still many questions. Br J Haematol 2013;161:177-82.
12. Franchini M, Mannucci PM. Gastrointestinal angiodysplasia and bleeding in von Willebrand disease. Thromb Haemost 2014;112:427-31.
13. Makris M. Gastrointestinal bleeding in von Willebrand disease. Thromb Res 2006;118:S13-7.
14. Siragusa S, Malato A, Lo Coco L, et al. Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management. Haemophilia 2008;14:150-2.
15. Swanson E, Mahgoub A, MacDonald R, Shaukat A. Medical and endoscopic therapies for angiodysplasia and gastric antral vascular ectasia: a systematic review. Clin Gastroenterol Hepatol 2014;12:571-82.
16. Franchini M, Frattini F, Crestani S, Bonfanti C. Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide. J Thromb Thrombolysis 2013;36:355-7.
17. Hirri HM, Green PJ, Lindsay J. Von Willebrand’s disease and angiodysplasia treated with thalidomide. Haemophilia 2006;12:285-6.
18. Garrido A, Sayago M, Lopez J, et al. Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias. Rev Esp Enferm Dig 2012;104:69-71.
19. Heidt J, Langers AM, van der Meer FJ, Brouwer RE. Thalidomide as treatment for digestive tract angiodysplasias. Neth J Med 2006;64:425-8.
20. Tan H, Chen H, Xu C, et al. Role of vascular endothelial growth factor in angiodysplasia: an interventional study with thalidomide. J Gastroenterol Hepatol 2012;27:1094-101.